Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer

NCT03192059 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Endometrial Cancer
Uterine Cancer

Interventions

DRUG: Pembrolizumab
RADIATION: Radiation
DRUG: Vitamin D
DRUG: Aspirin
DRUG: Lansoprazole
DRUG: Cyclophosphamide
DIETARY_SUPPLEMENT: Curcumin

Sponsor

University Hospital, Ghent

Collaborators

[object Object]
[object Object]